{"Title": "Preventing cardiovascular events with empagliflozin: At what cost?", "Year": 2015, "Source": "Lancet Diabetes Endocrinol.", "Volume": "3", "Issue": 12, "Art.No": null, "PageStart": 931, "PageEnd": null, "CitedBy": 1, "DOI": "10.1016/S2213-8587(15)00439-8", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84947917533&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Benzhydryl Compounds", "Cardiovascular Diseases", "Diabetes Mellitus, Type 2", "Female", "Glucosides", "Humans", "Hypoglycemic Agents", "Male"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-84947917533", "SubjectAreas": [["Internal Medicine", "MEDI", "2724"], ["Endocrinology, Diabetes and Metabolism", "MEDI", "2712"], ["Endocrinology", "BIOC", "1310"]], "AuthorData": {"24475357200": {"Name": "Naci H.", "AuthorID": "24475357200", "AffiliationID": "60003059", "AffiliationName": "LSE Health, Department of Social Policy, London School of Economics and Political Science"}, "9335409500": {"Name": "Basu S.", "AuthorID": "9335409500", "AffiliationID": "60032838", "AffiliationName": "Prevention Research Center, Centers for Health Policy, Primary Care, and Outcomes Research, Center on Poverty and Inequality"}, "24728579800": {"Name": "Yudkin J.S.", "AuthorID": "24728579800", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, University College London"}}}